HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 277, Issue 52, 50654-50659, December 27, 2002

This Article Full Text Full Text (PDF) All Versions of this Article: 277/52/50654    most recent M208330200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Prosise, G. L. Articles by Luecke, H. Search for Related Content PubMed PubMed Citation Articles by Prosise, G. L. Articles by Luecke, H. Social Bookmarking                      What's this?

Crystal Structure of Tritrichomonas foetus Inosine Monophosphate Dehydrogenase in Complex with the Inhibitor Ribavirin Monophosphate Reveals a Catalysis-dependent Ion-binding Site^*

Glen L. Prosise, Jim Zhen Wu^§, and Hartmut Luecke^¶

From the  Department of Molecular Biology and Biochemistry, University of California, Irvine, California 92697-3900 and ^§ Ribapharm, Costa Mesa, California 92626

Inosine monophosphate dehydrogenase (IMPDH) catalyzes the rate-limiting step in GMP biosynthesis. The resulting intracellular pool of guanine nucleotides is of great importance to all cells for use in DNA and RNA synthesis, metabolism, and signal transduction. The enzyme binds IMP and the cofactor NAD⁺ in random order, IMP is converted to XMP, NAD⁺ is reduced to NADH, and finally, NADH and then XMP are released sequentially. XMP is subsequently converted into GMP by GMP synthetase. Drugs that decrease GMP synthesis by inhibiting IMPDH have been shown to have antiproliferative as well as antiviral activity. Several drugs are in use that target the substrate- or cofactor-binding site; however, due to differences between the mammalian and microbial isoforms, most drugs are far less effective against the microbial form of the enzyme than the mammalian form. The high resolution crystal structures of the protozoan parasite Tritrichomonas foetus IMPDH complexed with the inhibitor ribavirin monophosphate as well as monophosphate together with a second inhibitor, mycophenolic acid, are presented here. These structures reveal an active site cation identified previously only in the Chinese hamster IMPDH structure with covalently bound IMP. This cation was not found previously in apo IMPDH, IMPDH in complex with XMP, or covalently bound inhibitor, indicating that the cation-binding site may be catalysis-dependent. A comparison of T. foetus IMPDH with the Chinese hamster and Streptococcus pyogenes structures reveals differences in the active site loop architecture, which contributes to differences in cation binding during the catalytic sequence and the kinetic rates between bacterial, protozoan, and mammalian enzymes. Exploitation of these differences may lead to novel inhibitors, which favor the microbial form of the enzyme.

The atomic coordinates and the structure factors (code 1ME8 and 1ME7) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				M. J. Page and E. Di Cera Role of na+ and k+ in enzyme function. Physiol Rev, October 1, 2006; 86(4): 1049 - 1092. [Abstract] [Full Text] [PDF]

				J. Oria-Hernandez, N. Cabrera, R. Perez-Montfort, and L. Ramirez-Silva Pyruvate Kinase Revisited: THE ACTIVATING EFFECT OF K+ J. Biol. Chem., November 11, 2005; 280(45): 37924 - 37929. [Abstract] [Full Text] [PDF]

				D. Benarroch, M.-P. Egloff, L. Mulard, C. Guerreiro, J.-L. Romette, and B. Canard A Structural Basis for the Inhibition of the NS5 Dengue Virus mRNA 2'-O-Methyltransferase Domain by Ribavirin 5'-Triphosphate J. Biol. Chem., August 20, 2004; 279(34): 35638 - 35643. [Abstract] [Full Text] [PDF]

				J. Vollmer, R. Rankin, H. Hartmann, M. Jurk, U. Samulowitz, T. Wader, A. Janosch, C. Schetter, and A. M. Krieg Immunopharmacology of CpG Oligodeoxynucleotides and Ribavirin Antimicrob. Agents Chemother., June 1, 2004; 48(6): 2314 - 2317. [Abstract] [Full Text] [PDF]